Skip to main content

Cipla 125 (Topiramate 200 mg)

Pill with imprint Cipla 125 is Pink, Capsule-shape and has been identified as Topiramate 200 mg. It is supplied by Cipla USA Inc.

Topiramate is used in the treatment of epilepsy; lennox-gastaut syndrome; seizure prevention; migraine prevention; seizures and belongs to the drug class carbonic anhydrase inhibitor anticonvulsants. There is positive evidence of human fetal risk during pregnancy. Topiramate 200 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for Cipla 125

Topiramate 200 mg Cipla 125
Topiramate 200 mg Cipla 125
Topiramate 200 mg Cipla 125 Front
Topiramate 200 mg Cipla 125 Back


Cipla 125
200 mg
Prescription only
Drug Class
Carbonic anhydrase inhibitor anticonvulsants
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Cipla USA Inc.
National Drug Code (NDC)
Inactive Ingredients
lactose monohydrate, hypromellose 2910 (6 mPa.s), hypromellose 2910 (3 mPa.s), magnesium stearate, polyethylene glycol 400, polysorbate 80, corn starch, sodium starch glycolate type A potato, titanium dioxide, microcrystalline cellulose, ferric oxide red

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Related images for "Cipla 125"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.